Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Sernova Corp. (SEOVF : OTC)

• Company Description    Sernova Corp. is a regenerative medicine company. It is engaged in developing medical technologies for the treatment of chronic debilitating metabolic diseases such as diabetes, blood disorders including hemophilia and other diseases treated through replacement of proteins or hormones missing or in short supply within the body. The company's implantable medical device for therapeutic cells consists of Cell Pouch(TM). Sernova Corp. is headquartered in London, Canada. Number of Employees:

• Price / Volume Information    Yesterday's Closing Price: $1.20 Daily Weekly Monthly 20 Day Moving Average: 100,929 shares Shares Outstanding: 262.63 (millions) Market Capitalization: $315.16 (millions) Beta: 1.17 52 Week High: $1.76 52 Week Low: $0.92 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 4.35% 13.88% 12 Week 8.11% 13.82% Year To Date -17.24% -3.53%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 700 COLLIP CIRCLE SUITE 114 - LONDON,A6 N6G 4X8 CAN ph: 877-299-4603 fax: 519-858-5099 info@sernova.com http://www.sernova.com

• General Corporate Information    Officers Philip M. Toleikis - President and Chief Executive Officer Frank Holler - Chairman David Swetlow - Chief Financial Officer James Parsons - Director Jeffrey Bacha - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 81732W104 SIC: 2834 Fiscal Year Fiscal Year End: October Last Reported Quarter: 01/01/22 Next Expected EPS Date: 06/24/22 Share - Related Items Shares Outstanding: 262.63 Most Recent Split Date: (:1) Beta: 1.17 Market Capitalization: $315.16 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 06/24/22

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 14.04 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -100.00% vs. Previous Quarter: -100.00% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 04/30/22 - - 01/31/22 - -36.34 10/31/21 - -27.92 ROA 04/30/22 - - 01/31/22 - -34.73 10/31/21 - -26.58 Current Ratio 04/30/22 - - 01/31/22 - - 10/31/21 - 19.19 Quick Ratio 04/30/22 - - 01/31/22 - - 10/31/21 - 19.19 Operating Margin 04/30/22 - - 01/31/22 - - 10/31/21 - - Net Margin 04/30/22 - - 01/31/22 - - 10/31/21 - - Pre-Tax Margin 04/30/22 - - 01/31/22 - - 10/31/21 - - Book Value 04/30/22 - - 01/31/22 - - 10/31/21 - 0.09 Inventory Turnover 04/30/22 - - 01/31/22 - - 10/31/21 - - Debt-to-Equity 04/30/22 - - 01/31/22 - - 10/31/21 - 0.01 Debt-to-Capital 04/30/22 - - 01/31/22 - - 10/31/21 - 0.97

Powered by Zacks Investment Research ©